(Q81315588)

English

Perspective: effect of rosiglitazone on cardiovascular outcomes

scientific article published on 01 September 2007

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

17877927

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17877927%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

title

Perspective: effect of rosiglitazone on cardiovascular outcomes (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

17877927

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17877927%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

1

Steven E Nissen

1 reference

stated in

Europe PubMed Central

PubMed ID

17877927

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17877927%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

publication date

1 September 2007

1 reference

stated in

Europe PubMed Central

PubMed ID

17877927

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17877927%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

published in

Current cardiology reports

1 reference

stated in

Europe PubMed Central

PubMed ID

17877927

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17877927%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

volume

9

1 reference

stated in

Europe PubMed Central

PubMed ID

17877927

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17877927%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

issue

5

1 reference

stated in

Europe PubMed Central

PubMed ID

17877927

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17877927%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

page(s)

343-344

1 reference

stated in

Europe PubMed Central

PubMed ID

17877927

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17877927%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

exact match

https://scigraph.springernature.com/pub.10.1007/bf02938358

0 references

cites work

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17877927

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17877927

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17877927

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17877927

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

(Q81315588)

Perspective: effect of rosiglitazone on cardiovascular outcomes

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)